Literature DB >> 17692262

[Hepatomegaly due to glycogen storage disease and type 1 diabetes mellitus].

M Flotats Bastardas1, M Miserachs Barba, A Ricart Cumeras, M Clemente León, M Gussinyer Canadell, D Yeste Fernández, María A Albisu Aparicio, A Carrascosa Lezcano.   

Abstract

Patients with type 1 diabetes and poor metabolic control can develop hepatomegaly due to intrahepatic glycogen deposition. If these patients also have elevated liver enzymes, dyslipidemia, cushingoid features and delayed growth or sexual maturation, Mauriac syndrome can be diagnosed. This disorder is common and reversible with optimization of insulin therapy. We report three adolescents with type 1 diabetes and a long-standing history of poor glycemic control, who developed hepatomegaly, elevated liver enzymes and dyslipidemia with preserved liver function. One of these patients also had delayed growth and another had hypogonadotropic hypogonadism. Liver ultrasound showed changes suggestive of glycogenosis. In all three patients, optimization of insulin therapy achieved good glycemic control and reversed the manifestations within 2 weeks. The etiology of Mauriac syndrome is controversial since both prolonged hyperglycemia and hyperinsulinization produce glycogen accumulation in the liver. Hypercortisolism (due to ketosis or hypoglycemia) contributes to glycogen storage and also causes growth and sexual maturation delay.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17692262     DOI: 10.1016/s1695-4033(07)70577-5

Source DB:  PubMed          Journal:  An Pediatr (Barc)        ISSN: 1695-4033            Impact factor:   1.500


  2 in total

Review 1.  Hepatic glycogenosis: An underdiagnosed complication of diabetes mellitus?

Authors:  María Teresa Julián; Núria Alonso; Isabel Ojanguren; Eduarda Pizarro; Enric Ballestar; Manel Puig-Domingo
Journal:  World J Diabetes       Date:  2015-03-15

2.  Mauriac Syndrome: A Rare Hepatic Glycogenosis in Poorly Controlled Type 1 Diabetes.

Authors:  Marta Patita; Gonçalo Nunes; António Alves de Matos; Hélder Coelho; Cristina Fonseca; Jorge Fonseca
Journal:  GE Port J Gastroenterol       Date:  2019-01-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.